Zobrazeno 1 - 10
of 26
pro vyhledávání: '"P S, Guseva"'
Autor:
Galina A. Khmeleva, Maria S. Guseva
Publikováno v:
RUDN Journal of Economics, Vol 32, Iss 1, Pp 113-134 (2024)
The evolution of international trade and trade policy has come a long way from mercantilism, A. Smith’s theory of absolute advantage, D. Ricardo’s comparative advantage. At present, there is no doubt that countries choose different models based o
Externí odkaz:
https://doaj.org/article/cc6fb757805f425c873ecde935eab5d4
Publikováno v:
Пищевые системы, Vol 6, Iss 3, Pp 350-357 (2023)
H-NMR spectroscopy was used to study the metabolic profile of Atlantic salmon muscle tissue during heat treatment and storage to assess the taste of products. It has been established that when steaming fish, the amount of compounds such as trimethyla
Externí odkaz:
https://doaj.org/article/e4c171b8dbdc48f0a26eb3a8340f5ea6
Publikováno v:
Пищевые системы, Vol 5, Iss 4, Pp 319-326 (2023)
The paper examines the problem of falsification of edible fish products, which concerns producers and consumers worldwide. Food products are most often falsified by imparting them some of the most typical features, for example appearance, upon the ov
Externí odkaz:
https://doaj.org/article/b1fa735f6d4d4d628e43a7d5cc289e13
Publikováno v:
Безопасность техногенных и природных систем, Vol 0, Iss 1, Pp 4-8 (2022)
Introduction. The paper discusses the methods for occupational risks assessment of workers within the framework of the labor protection management system. To date, there is no legally approved methodology for occupational risks assessment. Numerous w
Externí odkaz:
https://doaj.org/article/8ed96a4e991d45bdbd764070f5ed5e64
Publikováno v:
Пищевые системы, Vol 4, Iss 4, Pp 239-245 (2022)
In laboratory practice, there are many protein quantification methods, and all of them have their own advantages and disadvantages. The most common and widely used method for the protein analysis in food products, including fish, is the Kjeldahl meth
Externí odkaz:
https://doaj.org/article/1ff6997b15534e08989bbef897faa8e8
Autor:
M. S. Guseva, M. I. Doronin, A. A. Shishkova, D. V. Mikhalishin, M. A. Shevchenko, B. L. Manin
Publikováno v:
Ветеринария сегодня, Vol 1, Iss 1, Pp 15-21 (2021)
Compliance with the existing purity and safety requirements for immunobiologicals can be effectively achieved by the use of serum-free nutrient media and specialised supplements of non-animal origin. The paper shows the possibility of using Sheff-Vax
Externí odkaz:
https://doaj.org/article/c0b87fe92eff45268ac77ec9e7905726
Autor:
G. E. Rudenskaya, V. A. Kadnikova, O. P. Ryzhkova, L. A. Bessonova, E. L. Dadali, D. S. Guseva, T. V. Markova, D. N. Khmelkova, A. V. Polyakov
Publikováno v:
BMC Neurology, Vol 20, Iss 1, Pp 1-14 (2020)
Abstract Background Spastic paraplegia type 30 (SPG30) caused by KIF1A mutations was first reported in 2011 and was initially considered a very rare autosomal recessive (AR) form. In the last years, thanks to the development of massive parallel seque
Externí odkaz:
https://doaj.org/article/7e59f0dee73549889e88ab69b144c29c
Autor:
S. Guseva, T. Bleninger, K. Jöhnk, B. A. Polli, Z. Tan, W. Thiery, Q. Zhuang, J. A. Rusak, H. Yao, A. Lorke, V. Stepanenko
Publikováno v:
Hydrology and Earth System Sciences, Vol 24, Pp 697-715 (2020)
In recent decades, several lake models of varying complexity have been developed and incorporated into numerical weather prediction systems and climate models. To foster enhanced forecasting ability and verification, improvement of these lake models
Externí odkaz:
https://doaj.org/article/54f978e7742441a5af4a04b1bfcdb97c
Autor:
A. S. Galyavich, I. V. Fomin, I. R. Gaisin, F. V. Valeeva, N. G. Vinogradova, A. S. Salasyuk, E. I. Tarlovskaya, N. R. Khasanov, A. M. Shutov, E. N. Volodina, L. V. Grekhova, P. S. Guseva, D. V. Duplyakov, O. V. Zanozina, Yu. V. Zolotova, S. V. Kanysheva, Z. F. Kim, S. K. Kononov, V. P. Kuzmin, S. S. Markiyanova, M. V. Menzorov, S. A. Pomosov, A. P. Rebrov, S. N. Tolstov
Publikováno v:
Российский кардиологический журнал, Vol 26, Iss 4S (2022)
At an online meeting of experts held on May 14, 2021 additional research results on a sodium-glucose co-transporter-2 (SGLT2) inhibitor empagliflozin in patients with heart failure with reduced ejection fraction were considered. According to the data
Externí odkaz:
https://doaj.org/article/416a7910916a4eaea7d331bee92873fc
Autor:
S. V. Villevalde, A. S. Galyavich, N. G. Vinogradova, E. N. Volodina, I. R. Gaisin, S. R. Gilyarevsky, L. V. Grekhova, Yu. A. Guryanova, P. S. Guseva, D. V. Duplyakov, A. V. Ezhov, N. E. Zakirova, Yu. V. Zolotova, A. V. Isakov, S. V. Kanysheva, Z. F. Kim, V. P. Kuzmin, S. S. Markiyanova, S. A. Pomosov, A. P. Rebrov, E. I. Tarlovskaya, S. N. Tolstov, I. V. Fomin, N. R. Khasanov, A. M. Shutov
Publikováno v:
Российский кардиологический журнал, Vol 26, Iss 2S (2021)
An online meeting of experts held on November 6, 2020 describes the results of EMPA-REG OUTCOME and EMPEROR-Reduced trials on sodium-glucose co-transporter-2 (SGLT2) inhibitor empagliflozin. We analyzed cardiovascular and renal outcomes in patients w
Externí odkaz:
https://doaj.org/article/280165940e9842ad9ebdbae9d1c6f1fa